If you were recently diagnosed with ADHD as an adult, I invite you to listen to this webinar. I was asked to speak online LIVE for the Children and Adults with ADHD Association (CHADD) Webinar Series “Ask the Expert”. I discussed the benefits of ADHD treatment as they unfold over the first 6 months of treatment. If effectively treated with the sequence of medication and psychotherapy, there is a predictable pattern of improvement that can be expected. Understanding this pattern will help you discover what gets better and when. Patients and families are often amazed that I can predict what will happen over the first 6 months and you may be too.

Because it is a long all inclusive video, you may choose to watch two months at a time depending on where you are in treatment. I would encourage the ADD adult to share this video with family members in the house. It will faciliate discussion and help others understand how to be helpful.

I owe my patients the insight I have gained from their journey of distress to satisfication. Hopefully this is helpful to you.

David W. Goodman, M.D.

February 9 2020

Dr. David W. Goodman invited to speak at the Neuroscience Education Institute in Las Vegas, April 2020

David W. Goodman, MD Doctor's Blog, Patient Education adult ADD treatment, adult ADHD treatment, David W. Goodman MD, Dr. David W. Goodman, stimulant medication

A faculty speaker for the Neuroscience Education Institute (NEI) for many years, I have been invited to present several talks on adult ADHD and the complexity of medications. There are currently 28 different ADHD stimulant preparations (my last count). While there are only 4 different chemical compounds (methylphenidate, d-methylphenidate, amphetamine, d-amphetamine), the technologies delivering medication have exploded. With so many options, individual selection for each patient is possible. Good news for patients. Confusion for prescribers.

One of my presentations will focus on how to think through the medication options. How do you decide on the chemical compound? How do you select the delivery system? What medications interactions are concerning and what are not? Will side effects change if the deliver system is changed, even though the medication compound is the same?

Patients can help prescribers understand their experience with the medication by describing:

What positive cognitive effect do you notice with the medicine? What time do you take it and when do you notice it’s cognitive effect wearing off.
What side effects do you notice and when do they occur relative to taking the medication? Do the side effects occur 1-2 hours after taking medicine or do the side effects occur when it is wearing off? What side effects are subsiding and which ones are persisting?
Can you afford the medicine? There are large price difference between medications. Without understanding the range of options (remember: 28 different stimulant preparations), you may not know there is a more affordable option.
Can you swallow the medicine? There are several different forms: tablet, liquid, chewable, patch. All these forms have long-acting delivery systems so once daily dose is still possible.

The biggest challenge for prescribers now is the obstacle of insurance prior authorization and approval. This is an increasing frustration for patients and prescribers who work hard to find the right medication only to have insurance companies “decide” what medication is “appropriate” for you, the patient. Work with you prescriber to negotiate this obstacle course. Every time a patient changes insurance policy, these issues raise their head. Even if you have been stable on medication, the new insurance policy may deny future coverage. Oh, boy. Now that’s scary.

Believe it or not, I intended to describe my upcoming talks in April but got distracted by what I believe are important issues for patients to understand. It is the doctor in me to come back to the patient treatment and benefit.

Thank you for your valuable time. David W. Goodman, M.D.

Addendum: Because of COVID-19, this Neuroscience Education Institute conference was postponed and has been scheduled for Colorado Springs, Colorado November 5-8, 2020.

November 3 2018

Recognizing ADHD When You’re an Adult

David W. Goodman, MD Media Interviews, Magazines, Newspapers ADD medication, ADHD medication, adult ADD, adult ADD diagnosis, adult ADD education, adult ADD treatment, adult ADHD, Adult Attention Deficit Disorder, Adult Attention Deficit Hyperactivity Disorder, David W. Goodman MD

Read Article

June 12 2018

Review of Cardiovascular Effects of ADHD Medications

David W. Goodman, MD Clinician Articles, Professional Research Publications ADD medication, ADHD medication, adult ADD, adult ADD diagnosis, adult ADD education, adult ADD treatment, adult ADHD, Adult Attention Deficit Disorder, Adult Attention Deficit Hyperactivity Disorder, cardiovascular side effects with ADHD medication, CV risk from stimulants, David W. Goodman MD, heart effects from stimulants

Levin Charles J, Goodman David W, Adler Lenard A. Psychiatric Annals 2018

Click to read abstract

This scientific publication reviews the cardiovascular (CV) effects of ADHD medication and recommendations for monitoring clinical effects. The impression that ADHD medications cause significant CV risk is diminished when the literature is review and judicious monitoring of blood pressure and pulse are performed. Misinformation about CV risks is mitigated when the research literature is understood.

March 1 2017

A Randomized, 6-week, Placebo-Controlled Study of Treatment for Adult Attention-Deficit Disorder: Individualized Dosing of Osmotic-Release Oral System (OROS) Methylphenidate With a Goal of Symptom Remission

RoseMarie AddAdult Professional Research Publications adult ADD, adult ADD treatment, adult ADHD, adult ADHD treatment, Adult Attention Deficit Disorder, Adult Attention Deficit Hyperactivity Disorder, David W. Goodman MD, Goodman David MD, Treatment for ADD, Treatment for ADHD, Treatment for Adult Attention Hyperactivity Disorder, Treatment for Adult Attention-Deficit Disorder

Goodman DW, Starr LH, Yi-Wen M, Rostain AL, Ascher S. Armstron RB. J ClinPsychiatry 2017;78(1):105-114.

click to read abstract

January 1 2017

Mental Disorders in Primary Care: A Guide to Evaluation and Management

David W. Goodman, MD Clinician Articles ADD medication, ADHD medication, adult ADD, adult ADD diagnosis, adult ADD education, adult ADD treatment, adult ADHD, Adult Attention Deficit Disorder, Adult Attention Deficit Hyperactivity Disorder, David W. Goodman MD

Carvalho Andre F, McIntyre Roger S. Oxford Press, 2017.

Goodman, David W. “Adult ADHD across the lifespan” Chapter

This book is a comprehensive review of psychiatric disorders written for primary care providers. Each chapter is written by an expert specialist providing state-of-literature and clinical guidance for the diagnosis and treatment of mental disorders

January 1 2017

Effect of Online CME on Improving and Management: From Younger to Older Adults

David W. Goodman, MD Professional Research Publications ADD medication, ADHD medication, adult ADD, adult ADD diagnosis, adult ADD education, adult ADD treatment, adult ADHD, Adult Attention Deficit Disorder, Adult Attention Deficit Hyperactivity Disorder, David W. Goodman MD

Lubarda Jovana, Chatterjee Piyali, Goodman David W. Poster Presentation 2017

Click to read abstract